Global Director of Commercial Development Digital Pathology, Leica Biosystems
Mark Frushone is the Global Director of Commercial Development Digital Pathology at Leica Biosystems, based in Vista, California. With over 25 years of experience in the healthcare industry, Mark has been a prominent leader in the field.
He joined Leica Biosystems in 2012 as a Market Manager for Emerging Markets, focusing on global digital pathology enablement. Prior to this role, Mark served as a Senior Application Specialist for the indirect channel at Aperio. Mark has been involved in the laboratory and digital pathology space for over 15 years.
The Leica Biosystems-sponsored panel discussion, “Winning Strategies in the Next Decade in Pathology,” brought together pathology leaders to explore how digital pathology, AI enabled workflows, and predictive CDx are shaping the future of diagnostics. The session delivered a highly engaging and insightful exchange, combining thoughtful perspectives with moments of lighthearted dialogue among some of the top leaders in our industry.
